The Safety and Tolerability of STSA-1005 Following Intravenous Infusion in Healthy Subjects

NCT05085197 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: STSA-1005 injection
DRUG: Placebo
DRUG: STSA-1005 injection
DRUG: Placebo
DRUG: STSA-1005 injection
DRUG: Placebo
DRUG: STSA-1005 injection
DRUG: Placebo

Sponsor

Staidson Biopharma Inc.